Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2014 (2014), Article ID 627181, 10 pages
Research Article

Tetramethylpyrazine Protects against Hydrogen Peroxide-Provoked Endothelial Dysfunction in Isolated Rat Aortic Rings: Implications for Antioxidant Therapy of Vascular Diseases

1Guangdong Provincial Hospital of Chinese Medicine, No. 111 Dade Road, Guangzhou 510120, China
2Second College of Clinical Medicine, Guangzhou University of Chinese Medicine, No. 12 Jichang Road, Guangzhou 510405, China
3School of Biomedical Sciences, Chinese University of Hong Kong, Shatin, NT, Hong Kong

Received 24 February 2014; Revised 30 July 2014; Accepted 7 August 2014; Published 2 September 2014

Academic Editor: I-Min Liu

Copyright © 2014 Xiaojia Ni et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


Background and Objectives. Oxidative stress can initiate endothelial dysfunction and atherosclerosis. This study evaluated whether tetramethylpyrazine (TMP), the predominant active ingredient in Rhizoma Ligustici Wallichii (chuanxiong), prevents endothelial dysfunction in a rat model of oxidative stress. Methods. Isolated rat aortic rings were pretreated with various drugs before the induction of endothelial dysfunction by hydrogen peroxide (H2O2). Changes in isometric tension were then measured in acetylcholine- (ACh-) relaxed rings. Endothelial nitric oxide synthase (eNOS) expression was evaluated in the rings by Western blotting, and superoxide anion () content was assessed in primary rat aortic endothelial cells by dihydroethidium- (DHE-) mediated fluorescence microscopy. Results. ACh-induced endothelium-dependent relaxation (EDR) was disrupted by H2O2 in endothelium-intact aortic rings. H2O2-impaired relaxation was ameliorated by acute pretreatment with low concentrations of TMP, as well as by pretreatment with catalase and the NADPH oxidase inhibitors, apocynin and diphenyleneiodonium (DPI). TMP, apocynin, and DPI also reduced accumulation in endothelial cells,but TMP failed to alter eNOS expression in aortic rings incubated with H2O2. Conclusions. TMP safeguards against oxidative stress-induced endothelial dysfunction, suggesting that the agent might find therapeutic utility in the management of vascular diseases. However, TMP’s role in inhibiting NADPH oxidase and its vascular-protective mechanism of action requires further investigation.

1. Introduction

Excessive production of reactive oxygen species (ROS) by vascular endothelial cells contributes to endothelial dysfunction [1] which then initiates atherosclerosis [2]. Atherosclerosis is a progressive process that gradually leads to artery blockage. The clinical progression of atherosclerosis culminates in a number of devastating vascular events, including myocardial infarction and stroke [3]. Accordingly, patients with an ischemic complication of atherosclerosis experience a particularly vulnerable disease phase [4]. Currently, prevention and management of cardio-cerebrovascular diseases encompass the control of risk factors, as well as antithrombotic interventions [5, 6]. Additional efforts are directed toward interrupting ongoing oxidative processes in the vessel wall so as to prevent ROS-provoked endothelial impairment [7]. In this regard, antioxidants, which directly remove ROS threats, are emerging as one of the more promising treatments for vascular diseases in the recent years [8].

Rhizoma Ligustici Wallichii (Chinese name, chuanxiong), or lovage tuber, is commonly used in traditional Chinese medicine to promote blood circulation. Tetramethylpyrazine (TMP) is the predominant active component of Rhizoma Ligustici Wallichii [9], and the compound is noted for its potent vasodilating properties [10]. Like the parental herb, TMP (also called ligustrazine) is widely used to treat vascular diseases in China, with few adverse reactions in humans [11]. TMP has a long history of use, and the latest studies report its antioxidant proficiency in animal models of ischemic reperfusion [12], atherosclerosis [13], and cerebral vasospasm [14]. However, the underlying mechanism of TMP to combat detrimental ROS production and to rescue endothelial dysfunction in artery walls remains unclear.

Hydrogen peroxide (H2O2) acts as a relatively benign cell signaling molecule at low concentrations [15], but exposure of blood vessels to excessive amounts of H2O2 results in severe endothelial impairment [16]. In addition, H2O2 released during the progression of atherosclerosis is likely to worsen vascular damage [17]. In light of the protective effect of TMP in clinical and animal studies, we hypothesized that the administration of this compound to H2O2-compromised blood vessels could prevent endothelial dysfunction. The actions of acute TMP pretreatment on endothelium-dependent relaxation (EDR) and the protein expression levels of endothelial nitric oxide synthase (eNOS) were, therefore, evaluated in isolated rat aortic rings under various experimental conditions. We also explored the preventative effect of TMP against H2O2-provoked generation of the superoxide anion , a particularly harmful ROS, in primary cultures of endothelial cells established from the rat aorta.

2. Materials and Methods

2.1. Drugs and Reagents

TMP was purchased from the National Institutes for Food and Drug Control (Beijing, China). Phenylephrine (Phe), acetylcholine (ACh), apocynin, diphenyleneiodonium (DPI), vitamin E, catalase, Tiron (4,5-dihydroxy-1,3-benzene-disulfonic acid), and diethyldithiocarbamic acid (DETCA) were purchased from Sigma-Aldrich (St. Louis, MO, USA). Dihydroethidium (DHE) was purchased from Molecular Probes (Eugene, OR, USA). Losartan was purchased from Cayman Chemical Co. (Ann Arbor, MI, USA). Apocynin and losartan were dissolved in dimethyl sulfoxide (DMSO), and the other compounds were dissolved in distilled water. The DMSO vehicle did not affect ACh-induced aortic ring relaxation at the concentration employed in this study (0.1% v/v).

2.2. Blood Vessel Preparation

All animal experiments were approved by the Animal Experimentation Ethics Committee of the Chinese University of Hong Kong (Approval no. 4362/04 M). Male Sprague Dawley rats aged 6-7 months (260–280 g) were supplied by the Animal Service Center for the Chinese University of Hong Kong and euthanized by carbon dioxide inhalation. Aortas were isolated and dissected as previously described [18].

Briefly, the thoracic segment of each aorta was excised, removed of the surrounding adipose tissue, and cut into rings approximately 3 mm long in ice-cold oxygenated Krebs solution that consisted of 119 mM NaCl, 4.7 mM KCl, 2.5 mM CaCl2, 1 mM MgCl2, 25 mM NaHCO3, 1.2 mM KH2PO4, and 11 mM D-glucose. The rings were then suspended between stainless stain wires in 10-mL organ baths containing Krebs solution bubbling with 95% O2 plus 5% CO2 at 37°C. A basal tension of 20 mN was applied to all rings. The rings were exposed to 0.3 μM Phe to test smooth muscle contractility and then were relaxed by the addition of 3 μM ACh to assess the integrity of the endothelium. In some cases, the endothelial layer was mechanically disrupted by gently rubbing the lumen against the tips of a pair of forceps. Removal of the endothelium was confirmed by the lack of relaxation in the presence of 3 μM ACh. The rings were rinsed several times in prewarmed Krebs solution until baseline tension returned and then were used in isometric tension measurement experiments, as described below.

2.3. Isometric Tension Measurement

Contraction was once again induced in the aortic rings by exposure to 0.3 μM Phe. A gradient of ACh (3 nM–10 μM) was cumulatively added to induce relaxation of the rings when the contraction response reached a plateau, so as to obtain a concentration-response curve for ACh-mediated relaxation. The rings were again rinsed in prewarmed Krebs solution until baseline tension returned, followed by pretreatment with various compounds, as described below, and exposure to H2O2 (200 μM, 60 min). Thereafter, a second Ach concentration-response curve was obtained to examine any changes in the EDR imposed by H2O2 or the drugs.

The first series of experiments was designed to investigate whether TMP pretreatment could rescue endothelial dysfunction provoked by H2O2. The aortic rings were incubated with various concentrations (100 μM, 1 μM, or 10 nM) of TMP for 60 min and subsequently treated with H2O2 (200 μM) for 60 min. For comparison, the effects of losartan (1 μM, 30 min), a newly identified antioxidant agent [19], and vitamin E (100 μM, 30 min), a classical antioxidant [20], were also tested.

The next series of experiments was designed to explore the underlying mechanism of H2O2-induced EDR impairment. The rings were separately pretreated for 30 min with catalase (20000 U/mL), an enzyme that catalyzes the decomposition of H2O2 to water and molecular oxygen [21], and two inhibitors of NADPH oxidase, apocynin (10 μM) and DPI (10 nM) [22, 23]. After catalase, apocynin, or DPI pretreatment, the rings were exposed to H2O2 (200 μM) for 60 min.

2.4. Western Blotting

Western blotting analysis was performed as previously described [24]. Briefly, aortic rings were snap frozen in liquid nitrogen and homogenized in ice-cold RIPA lysis buffer. The lysates were centrifuged, and the supernatants were collected. Protein concentrations in each sample were determined by the Lowry method. Equal amounts of protein (50 μg per sample) were resolved in 10% sodium dodecyl sulfate- (SDS-) polyacrylamide gels and then transferred to nitrocellulose immobilon-P polyvinylidenedifluoride membranes. The membranes were blocked for 1 h at room temperature with 1% bovine serum albumin and incubated overnight at 4°C with a primary antibody against eNOS (1 : 3000) (BD Transduction Laboratories, Lexington, KY, USA) and a primary antibody against the loading control, glyceraldehyde 3-phosphate dehydrogenase (GAPDH, 1 : 3000) (Ambion, Austin, TX, USA). The membranes were then incubated with the corresponding horseradish peroxidase-conjugated secondary antibody (DakoCytomation, Carpinteria, CA, USA) for 1 h at room temperature. Immunoreactive polypeptide bands were visualized by using an enhanced chemiluminescence detection system, followed by exposure to X-ray film. Densitometry was performed by using a FluorChem documentation program (Alpha Innotech Corp., San Leandro, CA, USA) to measure the eNOS and GAPDH integrated density values (IDVs) of the aortic rings for each experimental condition.

2.5. Rat Aortic Endothelial Cell Culture

Primary rat aortic endothelial cells were cultured as previously described [25]. Briefly, aortas were isolated, cut open longitudinally, and digested with 0.2% collagenase directed against type 1A collagen (Sigma-Aldrich) for 15 min in a 37°C shaking water bath. RPMI medium supplemented with 10% fetal bovine serum and 1% penicillin/streptomycin was added to the cell suspension, and the cell suspension was then centrifuged at 1500 ×g for 10 min. The cell pellet was resuspended in the supplemented RPMI medium, and the cells were plated into culture flask (25 cm2) and allowed to settle for 1 h. At this time, the medium was changed to remove nonadherent cells. After the adherent cells reached 80% confluence, they were seeded onto coverslips in 6-well trays, pretreated with various drugs as described below, exposed to H2O2 (200 μM, 60 min), and subjected to DHE-mediated fluorescence microscopy for the detection of H2O2-generated intracellular ROS/.

2.6. ROS/ Detection via DHE-Mediated Fluorescence Microscopy

Intracellular ROS/ levels were examined in the primary rat aortic endothelial cells by using DHE-mediated fluorescence microscopy. The oxidation of DHE by intracellular ROS releases ethidium, which binds to DNA to emit fluorescence. The cells were pretreated at 37°C with TMP (10 nM, 60 min), apocynin (10 μM, 30 min), DPI (10 nM, 30 min), Tiron (100 μM) plus DETCA (1 mM) (30 min), or untreated control (60 min); exposed to H2O2 (200 μM, 60 min); and then incubated with DHE (5 μM, 20 min). Tiron, an scavenger, and DETCA, an generator, were utilized to confirm the production of in the endothelial cells following exposure to H2O2.

After incubation with DHE, the cells were rinsed with phosphate buffered saline, and the fluorescence of DNA-bound ethidium was measured under a FluoView Confocal Microscope (Olympus, Center Valley, PA, USA). The microscope was equipped with a 585-nm long pass filter and operated at an excitation wavelength of 515 nm. The fluorescence intensity of each sample was analyzed by using FluoView FV10-ASW software, version 1.5 (Olympus). The summarized data represent fold-changes in fluorescence intensity relative to that of the control, which was set to a value of 100%.

2.7. Statistical Analysis

All quantifiable data are expressed as the mean ± the standard error of the mean (SEM). GraphPad Prism software, version 6.0 (GraphPad Software, Inc., La Jolla, CA, USA), was used for data analysis. The vasorelaxing effect of TMP and other drugs was expressed as the percentage reduction of the Phe-evoked contraction. Nonlinear regression curve fitting was performed on individual cumulative Ach concentration-response curves to estimate the (maximal response) and the pD2 (negative logarithm of the EC50, where the EC50 represents the drug concentration that induces 50% of ) for each experimental agent (H2O2 or drug) or combination of agents. Thus, is a measure of effectiveness and pD2 is a measure of potency.

The concentration-response curves were analyzed by two-way analysis of variance (ANOVA) followed by the Bonferroni post hoc test. The statistical significance of the Western blotting data and the DHE-mediated fluorescence microscopy data was determined by one-way ANOVA followed by the Bonferroni post hoc test. In each case, a value of less than 0.05 was considered significant.

3. Results

3.1. TMP Protects against H2O2-Provoked Endothelial Dysfunction

Phe (0.3 μM) was utilized to provoke contraction in aortic rings isolated from adult Sprague Dawley rats, while ACh was employed to induce EDR in the Phe-contracted rings. ACh-induced EDR was markedly impaired in the rat aortic rings after 60 min exposure to H2O2 (200 μM) (Table 1, Figure 1). However, TMP pretreatment for 60 min at concentrations of 10 nM, 1 μM, and 100 μM significantly reversed the endothelial impairment provoked by H2O2. TMP and losartan, the newly identified antioxidants, showed similar effects at 1 μM (Table 1), while pretreatment with 100 μM vitamin E, a classical antioxidant, did not greatly reverse the endothelial damage (Table 1, Figure 1).

Table 1: Effects of TMP, losartan, and vitamin E on H2O2-provoked endothelial dysfunction in isolated rat aortic rings.
Figure 1: Tetramethylpyrazine (TMP) protects against hydrogen peroxide- (H2O2-) induced endothelial dysfunction. Phenylephrine (Phe, 0.3 μM) was utilized to provoke contraction in isolated rat aortic rings, and acetylcholine (ACh, 3 nM–10 μM) was utilized to induce EDR in the Phe-contracted rings. (a) Representative traces of ACh-induced EDR in H2O2 (200 μM)-exposed rings, with and without TMP (10 nM) pretreatment, and control rings. (b), (c) Effects of various drug treatments on H2O2-provoked disruption of ACh-induced EDR. The graphs share the same data for the control and H2O2-treated groups. Data represent the mean ± the standard error of the mean (SEM) of 4–6 independent experiments ( versus control; versus H2O2).
3.2. H2O2-Provoked Endothelial Dysfunction Is Reversed by Catalase and NADPH Oxidase Inhibitors

Catalase is a H2O2 scavenger that reduces H2O2 levels by converting the superoxide anions into water and molecular oxygen. Catalase (20000 U/mL, 30 min) pretreatment of rat aortic rings significantly prevented the H2O2-mediated disruption of ACh-induced EDR, albeit only partially (Table 2, Figure 2), suggesting that H2O2 exerts both direct and indirect effects to induce endothelial dysfunction. In support of this hypothesis, separate pretreatment of the rings with the NADPH oxidase inhibitors, apocynin (10 μM, 30 min) and DPI (10 nM, 30 min), also significantly blocked the induction of vascular dysfunction by H2O2 (Table 2, Figure 2).

Table 2: Effects of catalase, apocynin, and DPI on H2O2-provoked endothelial dysfunction in isolated rat aortic rings.
Figure 2: Hydrogen peroxide (H2O2)-induced endothelial dysfunction is reversed by catalase and NADPH oxidase inhibitors. (a) Representative traces of acetylcholine- (ACh-) induced endothelium-dependent relaxation (EDR) in H2O2- (200 μM) treated rings with catalase (20000 U/mL), apocynin (10 μM), or diphenyleneiodonium (DPI, 10 nM) pretreatment. (b) Effects of catalase, apocynin, and DPI on H2O2-provoked disruption of ACh-induced EDR. Data represent the mean ± the standard error of the mean (SEM) of 4–6 independent experiments ( versus control; versus H2O2).
3.3. TMP Does Not Rescue EDR by Altering eNOS Expression

Nitric oxide acts as a vasodilator and is produced through the actions of eNOS in the endothelium. Therefore, we reasoned that agents with the capacity to influence the EDR in rat aortic rings might have an effect on eNOS expression. However, none of the experimental conditions employed (Phe; Phe plus ACh; H2O2 (200 μM, 60 min); TMP (10 nM, 60 min) plus H2O2; or losartan (1 μM, 30 min) plus H2O2) had any effect on eNOS expression  in aortic rings with an intact endothelium, as assessed on Western blots (Figure 3) and by comparing the eNOS IDV/GAPDH IDV ratio for each experimental condition (Table 3, Figure 3). On the other hand, the endothelium-denuded group with no drug treatment showed significantly decreased eNOS expression relative to any group with an intact endothelium (Table 3, Figure 3).

Table 3: eNOSIDV/GAPDH IDV ratios in isolated rat aortic rings.
Figure 3: Tetramethylpyrazine (TMP) does not rescue endothelium-dependent relaxation (EDR) through actions on endothelial nitric oxide synthase (eNOS) expression. Rat aortic rings were subjected to various experimental conditions (phenylephrine (Phe); Phe plus acetylcholine (ACh); hydrogen peroxide (H2O2, 200 μM); TMP (10 nM) plus H2O2; losartan (1 μM) plus H2O2; or removal of the endothelium). The bar graph shows the ratio of the eNOS integrated density value (IDV) to the glyceraldehyde 3-phosphate dehydrogenase (GAPDH) IDV for each experimental condition. Data represent the mean ± the standard error of the mean (SEM) of 5–8 independent experiments.
3.4. TMP, NADPH Oxidase Inhibitors, and the ROS Scavenger, Tiron, Prevented the Production of in H2O2-Exposed Rat Aortic Endothelial Cells

Finally, we evaluated the ROS/ content in primary cultures of H2O2-exposed rat aortic endothelial cells with and without drug pretreatment, because is a highly damaging species linked to substantial cytotoxicity in vascular endothelial cells. H2O2 (200 μM, 60 min) triggered substantial ROS generation compared with the control group, as determined by a significant increase in fluorescence intensity attributable to ethidium-bound DNA. However, the fluorescence intensity was significantly blocked by pretreatment with TMP (10 nM, 60 min), apocynin (10 μM, 30 min), DPI (10 nM, 30 min), or Tiron (an ROS scavenger) (100 μM, 30 min) plus DETCA (a superoxide dismutase inhibitor that increases intracellular content) (1 mM, 30 min) (Table 4, Figure 4).

Table 4: DHE-mediated fluorescence microscopy assay in primary rat aortic endothelial cells.
Figure 4: Tetramethylpyrazine (TMP), apocynin, diphenyleneiodonium (DPI), and Tiron prevent hydrogen peroxide- (H2O2-) induced production of the superoxide anion () in primary rat aortic endothelial cells. production was detected by the dihydroethidium- (DHE-) mediated fluorescence microscopy assay. Cells were treated with H2O2 (200 μM) alone or in combination with TMP (10 nM), apocynin (10 μM), DPI (10 nM), or Tiron (10 nM) plus diethyldithiocarbamic acid (DETCA) (1 mM) pretreatment. The bar graph shows the fluorescence intensity (%) of each experimental group relative to the control. Data represent the mean ± the standard error of the mean (SEM) of 3–9 independent experiments ( versus control; versus H2O2).

4. Discussion

Vascular events (death from all vascular causes, nonfatal stroke, or nonfatal myocardial infarction) are complex occurrences caused by multiple factors, and ROS-induced endothelial injury is suggested to be the common denominator in most vascular conditions [26]. Consequently, antioxidant therapy, which directly targets the common mediator of vascular disorders, shows great promise for the prevention and management of cardio-cerebrovascular diseases.

The current study explored the capacity of acute pretreatment with TMP, an antioxidant constituent of Rhizoma Ligustici Wallichii, to overturn the H2O2-mediated impairment of ACh-induced relaxation in the rat aorta. We found that the exposure of rat aortic rings to TMP prior to H2O2 treatment did indeed thwart the actions of H2O2 to promote endothelial dysfunction (Table 1, Figure 1). TMP was effective at surprisingly low doses (i.e., nM levels), yet vitamin E, a classical antioxidant, did not provide the same protective benefits at a considerably higher concentration (100 μM) (Table 1, Figure 1). This may be due to the use of high concentration of H2O2 (200 μM) to induce impaired EDR and the potent antioxidant effect of TMP. The protective effect of TMP by reduction of oxidative stress in the present study is consistent with other studies working in different systems [12, 13, 2729].

H2O2 is a relatively stable ROS with dual functions in the vasculature, depending on its effective concentration. For example, low levels of H2O2 maintain the physiology of vascular endothelial cells [30], and H2O2 seldom exerts vascular damage in the absence of unpaired electrons [31]. Therefore, drugs which are capable of stimulating superoxide dismutase to transform into oxygen and H2O2 are regarded as protective agents [32]. However, increasing evidence demonstrates that substantial exposure to H2O2 at high concentrations (i.e., >100 μM) contributes to vascular injury and associated inflammatory responses, vascular endothelial cell cytotoxicity and apoptosis, and even vascular events [33]. The present study therefore exposed the isolated rat aortic rings to high levels of H2O2 (200 μM) for 60 min, with the goal of establishing an in vitro model of oxidative stress-induced endothelial dysfunction. Given that ACh-induced relaxation is endothelium-dependent and reflects normal endothelium functionality [34], H2O2-induced disruption of ACh-stimulated EDR mimics the pathophysiology of ROS-triggered vascular diseases.

Interestingly, TMP or losartan pretreatment of H2O2-exposed aortic rings did not rescue EDR by altering eNOS expression (Table 3, Figure 3), although H2O2 reportedly affects endothelial function by modulating Enos content in the rabbit aorta [35]. In particular, low levels of the ROS exert vasorelaxing effects via eNOS upregulation of nitric oxide [35], suggesting that high concentrations of H2O2, such as that used herein, might impair EDR by downregulating eNOS content. Nonetheless, this was not the case (Table 3, Figure 3). The protective effect of TMP to H2O2-induced endothelial dysfunction in the present study may be due to the reported TMP-mediated activation of eNOS activity through PI3K/Akt and phosphorylation of eNOS at Ser1177 for increased generation of NO in myocardial ischaemia reperfusion [12]. At the same time, TMP can alleviate oxidative stress by increased total antioxidant activity and SOD1 activity [13]. Furthermore, catalase, a strong H2O2 scavenger [21], only partially reversed the impairment of EDR by H2O2 (Table 2, Figure 2). Hence, H2O2 may indirectly as well as directly harm the vascular endothelium.

An earlier investigation indicated that H2O2 can activate NADPH oxidase to produce in vitro [36]. We therefore pretreated rat aortic rings with two different NADPH inhibitors, apocynin and DPI, prior to H2O2 exposure and found that the drugs significantly safeguarded the aortas from ROS insult, and rescued EDR (Table 2, Figure 2). We also conducted DHE-mediated fluorescence measurements in cultured primary rat aortic endothelial cells to investigate the impact of H2O2 and various drugs on intracellular content. As a result, H2O2 enhanced levels, while pretreatment with TMP, apocynin, DPI, or Tiron plus DETCA prevented this action (Table 4, Figure 4). This exciting finding implies that is produced in response to exposure of the vascular endothelium to oxidative stress, which is potentially mediated via the stimulation of NADPH oxidase. On the other hand, it is still possible that H2O2 exposure to rat aortic rings may increase ROS generation from mitochondria due to increased oxidative stress. TMP could improve the impaired EDR by reduction of mitochondrial ROS production [27]. We cannot exclude this possible mechanism although its contributory role may not be significant. At the same time, it has been shown that the antioxidant effect of TMP likely is due to its ability of the mitochondrial biogenesis [28].

The possibility that TMP averts H2O2-provoked endothelial dysfunction by inhibiting NADPH oxidase is supported by our findings that its actions were similar to those of apocynin and DPI in both isolated aortic rings (compare Table 1 with Figure 1 and Table 2 with Figure 2) and primary aortic endothelial cells (Table 4, Figure 4). NADPH oxidase is a key generator of ROS in blood vessel walls during the progression of vascular disease [37]. An unequivocal demonstration of the TMP-mediated suppression of NADPH oxidase expression/activity under pathological conditions, with a concomitant reduction in the overproduction of and other ROS, would undeniably strengthen our proposal that TMP might serve as a new antioxidant agent for the management of vascular diseases. However, this hypothesis requires further investigation, especially in regard with determining the NADPH oxidase and levels in rat aortic rings post-TMP treatment.

Other possible alternative mechanisms may be offered by TMP to protect endothelial dysfunction. The protective effect of TMP may be due to its action to induce anti-inflammatory effect in endothelium. TMP has been shown to reverse the decrease of NO production induced by TNF-α and inhibit the downregulated expression of intracellular adhesion molecular-1 and heat shock protein 60 mediated by TNF-α, suggesting that TMP may protect endothelium through inhibition of immunological reactions [29]. In addition, TMP treatment has been shown to prevent the increment of both inducible NO synthase and TNF-α expression [38], improving survival of rodent model of endotoxic shock induced by lipopolysaccharide [39]. TMP has also been demonstrated to protect streptozotocin-induced diabetic rats by downregulated expression of vascular endothelial growth factor [40].

5. Conclusions

In conclusion, the present study showed that TMP prevented oxidative stress-induced endothelial dysfunction in isolated rat aortic rings without affecting eNOS expression. In addition, TMP reduced accumulation in H2O2-exposed primary rat aortic endothelial cells. The NADPH oxidase inhibitors, apocynin and DPI, displayed the same actions as TMP in both in vitro models. These results suggest that TMP might find therapeutic utility as an efficacious antioxidant for the treatment of human cardio-cerebrovascular diseases and warrant further exploration of its actions in whole-animal models and preclinical studies. However, the role of TMP in inhibiting NADPH oxidase remains to be elucidated.


ANOVA:Analysis of variance
DETCA:Diethyldithiocarbamic acid
EDR:Endothelium-dependent relaxation
:Maximal response
eNOS:Endothelial nitric oxide synthase
GAPDH:Glyceraldehyde 3-phosphate dehydrogenase
H2O2:Hydrogen peroxide
IDV:Integrated density value
:Superoxide anion
pD2:Negative logarithm of the EC50 (drug concentration that induces 50% of the )
ROS:Reactive oxygen species
SDS:Sodium dodecyl sulfate
SEM:Standard error of the mean
SOD:Superoxide dismutase

Conflict of Interests

The authors declare that there is no conflict of interests regarding the publication of this paper.


This study was supported by the Guangdong Provincial Natural Science Foundation of China (Grant no. 9451040701003684).


  1. J. Loscalzo, “Oxidant stress: A key determinant of atherothrombosis,” Biochemical Society Transactions, vol. 31, no. 5, pp. 1059–1061, 2003. View at Publisher · View at Google Scholar · View at Scopus
  2. M. Mudau, A. Genis, A. Lochner, and H. Strijdom, “Endothelial dysfunction: the early predictor of atherosclerosis,” Cardiovascular Journal of Africa, vol. 23, no. 4, pp. 222–231, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. J. Frostegård, “Immunity, atherosclerosis and cardiovascular disease,” BMC Medicine, vol. 11, article 117, 2013. View at Publisher · View at Google Scholar
  4. P. Dutta, G. Courties, Y. Wei et al., “Myocardial infarction accelerates atherosclerosis,” Nature, vol. 487, no. 7407, pp. 325–329, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. L. B. Goldstein, C. D. Bushnell, R. J. Adams et al., “Guidelines for the primary prevention of stroke: a guideline forhealthcare professionals from the American Heart Association/American StrokeAssociation,” Stroke, vol. 42, no. 2, pp. 517–584, 2011. View at Google Scholar
  6. P. O. Vandvik, A. M. Lincoff, J. M. Gore et al., “Primary and secondary prevention of cardiovascular disease: antithrombotic therapy and prevention of thrombosis, 9th ed: American college of chest physicians evidence-based clinical practice guidelines,” Chest, vol. 141, no. 2, supplement, pp. e637S–e668S, 2012. View at Publisher · View at Google Scholar
  7. A. R. Weseler and A. Bast, “Oxidative stress and vascular function: implications for pharmacologic treatments,” Current Hypertension Reports, vol. 12, no. 3, pp. 154–161, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. A. Spychalowicz, G. Wilk, T. Śliwa, D. Ludew, and T. J. Guzik, “Novel therapeutic approaches in limiting oxidative stress and inflammation,” Current Pharmaceutical Biotechnology, vol. 13, no. 13, pp. 2456–2466, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. T. Kosuge and H. Kamiya, “Discovery of a pyrazine in a natural product: tetramethylpyrazine from cultures of a strain of bacillus subtilis,” Nature, vol. 193, no. 4817, p. 776, 1962. View at Publisher · View at Google Scholar · View at Scopus
  10. W. Peng, D. Hucks, R. M. Priest, Y. M. Kan, and J. P. T. Ward, “Ligustrazine-induced endothelium-dependent relaxation in pulmonary arteries via an NO-mediated and exogenous L-arginine-dependent mechanism,” British Journal of Pharmacology, vol. 119, no. 5, pp. 1063–1071, 1996. View at Publisher · View at Google Scholar · View at Scopus
  11. Y. R. Jiang and K. J. Chen, “Pharmacological roles of ligustrazine incardio-/cerebrovascular systems and its progress in researches of clinical application,” Chinese Journal of Integrated Traditional and Western Medicine, vol. 33, no. 5, pp. 707–711, 2013. View at Google Scholar
  12. L. Lv, S.-S. Jiang, J. Xu, J.-B. Gong, and Y. Cheng, “Protective effect of ligustrazine against myocardial ischaemia reperfusion in rats: the role of endothelial nitric oxide synthase,” Clinical and Experimental Pharmacology and Physiology, vol. 39, no. 1, pp. 20–27, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. F. Jiang, J. Qian, S. Chen, W. Zhang, and C. Liu, “Ligustrazine improves atherosclerosis in rat via attenuation of oxidative stress,” Pharmaceutical Biology, vol. 49, no. 8, pp. 856–863, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. Z. Shao, J. Li, Z. Zhao, C. Gao, Z. Sun, and X. Liu, “Effects of tetramethylpyrazine on nitric oxide/cGMP signaling after cerebral vasospasm in rabbits,” Brain Research, vol. 1361, pp. 67–75, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. E. Veal and A. Day, “Hydrogen peroxide as a signaling molecule,” Antioxidants and Redox Signaling, vol. 15, no. 1, pp. 147–151, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. B. M. Boulden, J. D. Widder, J. C. Allen et al., “Early determinants of H2O2-induced endothelial dysfunction,” Free Radical Biology and Medicine, vol. 41, no. 5, pp. 810–817, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. H. Cai, “Hydrogen peroxide regulation of endothelial function: origins, mechanisms, and consequences,” Cardiovascular Research, vol. 68, no. 1, pp. 26–36, 2005. View at Publisher · View at Google Scholar · View at Scopus
  18. C. M. Wong, L. M. Yung, F. P. Leung et al., “Raloxifene protects endothelial cell function against oxidative stress,” British Journal of Pharmacology, vol. 155, no. 3, pp. 326–334, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. M. Kamper, O. Tsimpoukidi, A. Chatzigeorgiou, M. Lymberi, and E. F. Kamper, “The antioxidant effect of angiotensin II receptor blocker, losartan, in streptozotocin-induced diabetic rats,” Translational Research, vol. 156, no. 1, pp. 26–36, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. G. W. Burton, A. Joyce, and K. U. Ingold, “First proof that vitamin E is major lipid-soluble, chain-breaking antioxidant in human blood plasma,” The Lancet, vol. 2, no. 8293, p. 327, 1982. View at Google Scholar · View at Scopus
  21. V. R. Muzykantov, “Targeting of superoxide dismutase and catalase to vascular endothelium,” Journal of Controlled Release, vol. 71, no. 1, pp. 1–21, 2001. View at Publisher · View at Google Scholar · View at Scopus
  22. M. S. Petrônio, M. L. Zeraik, L. M. Da Fonseca, and V. F. Ximenes, “Apocynin: chemical and biophysical properties of a NADPH oxidase inhibitor,” Molecules, vol. 18, no. 3, pp. 2821–2839, 2013. View at Publisher · View at Google Scholar · View at Scopus
  23. A. Sebastian, A. Radermacher Kim, W. M. Kleikers Pamela, W. Kirstin, and H. H. W. Schmidt Harald, “Evolution of NADPH oxidase inhibitors: selectivity and mechanisms for target engagement,” Antioxidants & Redox Signaling, 2014. View at Publisher · View at Google Scholar
  24. X. Y. Tian, L. H. Yung, W. T. Wong et al., “Bone morphogenic protein-4 induces endothelial cell apoptosis through oxidative stress-dependent p38MAPK and JNK pathway,” Journal of Molecular and Cellular Cardiology, vol. 52, no. 1, pp. 237–244, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. J. Dong, S. L. Wong, C. W. Lau et al., “Calcitriol restores renovascular function in estrogen-deficient rats through downregulation of cyclooxygenase-2 and the thromboxane-prostanoid receptor,” Kidney International, vol. 84, no. 1, pp. 54–63, 2013. View at Publisher · View at Google Scholar · View at Scopus
  26. H. Li, S. Horke, and U. Förstermann, “Oxidative stress in vascular disease and itspharmacological prevention,” Trends in Pharmacological Sciences, vol. 34, no. 6, pp. 313–319, 2013. View at Google Scholar
  27. X. Gao, X.-L. Zhao, Y.-H. Zhu et al., “Tetramethylpyrazine protects palmitate-induced oxidative damage and mitochondrial dysfunction in C2C12 myotubes,” Life Sciences, vol. 88, no. 17-18, pp. 803–809, 2011. View at Publisher · View at Google Scholar · View at Scopus
  28. Q. Xu, P. Xia, X. Li, W. Wang, Z. Liu, and X. Gao, “Tetramethylpyrazine ameliorates high glucose-induced endothelial dysfunction by increasing mitochondrial biogenesis,” PLoS ONE, vol. 9, no. 2, Article ID e88243, 2014. View at Google Scholar
  29. H.-J. Wu, J. Hao, S.-Q. Wang, B.-L. Jin, and X.-B. Chen, “Protective effects of ligustrazine on TNF-α-induced endothelial dysfunction,” European Journal of Pharmacology, vol. 674, no. 2-3, pp. 365–369, 2012. View at Publisher · View at Google Scholar · View at Scopus
  30. W. Dröge, “Free radicals in the physiological control of cell function,” Physiological Reviews, vol. 82, no. 1, pp. 47–95, 2002. View at Google Scholar
  31. B. Halliwell, M. V. Clement, and L. H. Long, “Hydrogen peroxide in the human body,” FEBS Letters, vol. 486, no. 1, pp. 10–13, 2000. View at Publisher · View at Google Scholar · View at Scopus
  32. T. Fukai and M. Ushio-Fukai, “Superoxide dismutases: role in redox signaling, vascular function, and diseases,” Antioxidants and Redox Signaling, vol. 15, no. 6, pp. 1583–1606, 2011. View at Publisher · View at Google Scholar · View at Scopus
  33. C. H. Coyle, L. J. Martinez, M. C. Coleman, D. R. Spitz, N. L. Weintraub, and K. N. Kader, “Mechanisms of H2O2-induced oxidative stress in endothelial cells,” Free Radical Biology and Medicine, vol. 40, no. 12, pp. 2206–2213, 2006. View at Publisher · View at Google Scholar · View at Scopus
  34. R. F. Furchgott and P. M. Vanhoutte, “Endothelium-derived relaxing and contracting factors,” The FASEB Journal, vol. 3, no. 9, pp. 2007–2018, 1989. View at Google Scholar · View at Scopus
  35. A. Zembowicz, R. J. Hatchett, A. M. Jakubowski, and R. J. Gryglewski, “Involvement of nitric oxide in the endothelium-dependent relaxation induced by hydrogen peroxide in the rabbit aorta,” British Journal of Pharmacology, vol. 110, no. 1, pp. 151–158, 1993. View at Publisher · View at Google Scholar · View at Scopus
  36. H. Cai, “NAD(P)H oxidase-dependent self-propagation of hydrogen peroxide and vascular disease,” Circulation Research, vol. 96, no. 8, pp. 818–822, 2005. View at Publisher · View at Google Scholar · View at Scopus
  37. A. Schramm, P. Matusik, G. Osmenda, and T. J. Guzik, “Targeting NADPH oxidases in vascular pharmacology,” Vascular Pharmacology, vol. 56, no. 5-6, pp. 216–231, 2012. View at Publisher · View at Google Scholar · View at Scopus
  38. M. H. Liao, C. C. Wu, and M. H. Yen, “Beneficial effects of tetramethylpyrazine, an active constituent of Chinese herbs, on rats with endotoxemia.,” Proceedings of the National Science Council, Republic of China. Part B, Life sciences, vol. 22, no. 1, pp. 46–54, 1998. View at Google Scholar · View at Scopus
  39. C.-C. Wu, M.-H. Liao, S.-J. Chen, and M.-H. Yen, “Tetramethylpyrazine prevents inducible NO synthase expression and improves survival in rodent models of endotoxic shock,” Naunyn-Schmiedeberg's Archives of Pharmacology, vol. 360, no. 4, pp. 435–444, 1999. View at Publisher · View at Google Scholar · View at Scopus
  40. Q. H. Yang, Y. Liang, Q. Xu, Y. Zhang, L. Xiao, and L. Y. Si, “Protective effect of tetramethylpyrazine isolated from Ligusticum chuanxiong on nephropathy in rats with streptozotocin-induced diabetes,” Phytomedicine, vol. 18, no. 13, pp. 1148–1152, 2011. View at Publisher · View at Google Scholar · View at Scopus